SNY
SanofiCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Bull case: successful late-stage readouts and positive guidance lift sentiment, leading to multiple expansion and ~+20% upside from the anchor amid stable fundamentals.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Adverse regulatory decisions
Momentum
18
Value
67
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $51.64 · Bull $62.00 · Bear $41.31
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $52.40
Why
Momentum18 · Δ7d +9.7
Value67 · Δ7d -0.3
Sentiment61 · Δ7d -6.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
18
26% active weight
Current posture
7d trendImproving
Δ7d
+9.7
Δ21d
+0.9
Value
67
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
+1.6
Sentiment
61
34% active weight
Current posture
7d trendSoftening
Δ7d
-6.7
Δ21d
-5.5
Why this grade
Composite grade C. Momentum 17.5 / Value 67.4 / Sentiment 61.3
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$107.77B
Beta
0.43
Shares Out
2.4B
P/E (TTM)
16.1
P/S (TTM)
2.35
P/FCF (TTM)
97.54
Rev YoY
-7.0%
EPS YoY
+3.1%
Gross Margin
+65.9%
Op Margin
+18.9%
Net Debt
$14.86B
Current Ratio
1.09
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology